Why is ENGN Up Today?

ENGN
$2.19
▲ +21.67% (+$0.47)
Last updated: Nov 12, 2026 8:30 PM ET (73 min ago)

About enGene Holdings Inc. Common Stock

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized d...

Sector: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Cap: $389.06M
Forward P/E: -2.9
52-Week Range: $1.40 - $12.25
Employees: 57

Overall Confidence: 65%

65% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 25.1%
This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

HIGH VOLUME 7.5x average volume

ACCUMULATION - This move is backed by significant volume and appears sustainable.

📍 Sector Context

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -3.4%

ENGN is outperforming its sector by 25.1%. This suggests a stock-specific catalyst.

Market Comparison

ENGN is significantly outperforming the market (+22.0% vs SPY)
S&P 500
SPY
-0.35%
Nasdaq 100
QQQ
-0.32%
ENGN
This Stock
+21.67%
vs S&P 500: +22.02%
vs Nasdaq: +21.99%

📊 What Happens Next?

Probability Analysis

55% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, ENGN is expected to trade between:
$2.15 - $2.26

Key Level to Watch

$2.30 resistance
Watch for continuation above $2.19

Quick Trade Ideas

Options strategies to consider for ENGN's 22% move

Protective Put

Protect gains from 22% rally with downside insurance

hedge
STRATEGY LEGS (Exp: Nov 20, 7 DTE)
BUY $2 PUT @ $0.05
Cost
$5
Max Profit
$14
Max Loss
$5
Breakeven
2.14
Limited loss, protects gains
Build Custom Strategy

Customize strikes, expirations, and see interactive P&L charts

Disclaimer: These are educational examples only, not investment advice. Options involve significant risk including total loss of premium. Prices shown are estimates and may differ from actual market prices. Always do your own research and consider your risk tolerance.

🔔 Get ENGN Alerts

We'll notify you when ENGN's trend changes or a new signal fires.

Last updated: Nov 12, 2026 8:30 PM (73 minutes ago)
Data refreshes every 30 minutes during market hours

Options Market Insight

Neutral
Options Sentiment
1.28
Put/Call Ratio
173.3%
Implied Volatility
Call Volume: 23,371
Put Volume: 29,902
Total: 53,273
Unusual Activity: $2 PUT (1,508 vol) $2 PUT (1,507 vol)

Historical Context

ENGN has moved more than 3.0% up on 55 occasions in the past year.

43.6%
Continuation Rate
24/55 times continued up
-0.48%
Avg Next Day Change
After similar up moves
Last similar move: Nov 11, 2026 (7.8%) → Next day: +21.7%

Frequently Asked Questions

Why is ENGN stock up today?

This stock is significantly outperforming its BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector peers, suggesting a stock-specific catalyst.

Is ENGN stock a buy or sell right now?

Based on current analysis, ENGN shows 65% confidence in today's move. Volume is high which supports the trend. View full buy/sell analysis →

What is the ENGN stock price target?

ENGN is currently trading at $2.19. Based on today's momentum, the expected short-term range is $2.15 - $2.26. See long-term price prediction →

Will ENGN stock continue rising?

Our analysis shows a 55% probability that ENGN's move continues in the next 1-3 days. Key level to watch: $2.30 (resistance).

Is ENGN stock oversold or overbought?

ENGN's RSI (Relative Strength Index) is currently at 72.4. This indicates overbought conditions - the stock may be due for a pullback as buying pressure appears stretched.

What is the momentum for ENGN stock?

ENGN's 10-day momentum indicator is at 0.75. Positive momentum - the stock has mild upward pressure supporting the current trend.

Is ENGN outperforming or underperforming the market?

ENGN (+21.67%) is currently significantly outperforming the market (+22.0% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.

What does MACD indicate for ENGN?

ENGN's MACD (0.04) is currently above the signal line (-0.02), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 24.0) is moderate.

Is ENGN in an uptrend or downtrend?

Based on moving average analysis, ENGN is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $1.66, 50-day SMA: $1.78.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL